Overview
A randomized trial of using EMLA cream for anesthesia to remove Nexplanon versus the standard route of subcutaneous lidocaine for anesthesia. Primary endpoints are pain during procedure and time to removal.
Eligibility
Inclusion Criteria:
- Females with Nexplanon implant in place, desiring removal No allergy to lidocaine or any component of EMLA cream Age greater than or equal to 18years English as primary language Not pregnant
Exclusion Criteria:
- pregnant non-emglish speaking age less than 18 yo Allergy to lidocaine or EMLA